{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:03:36Z","timestamp":1782738216995,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Moinhos de Vento Hospital"},{"name":"Programa de Apoio ao Desenvolvimento Institucional do Sistema \u00danico de Sa\u00fade"},{"name":"Ministry of Health"},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s00430-022-00758-1","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T10:12:19Z","timestamp":1670926339000},"page":"75-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17\u00a0T cell production"],"prefix":"10.1007","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9718-7243","authenticated-orcid":false,"given":"Fernanda Tereza Bovi","family":"Frozza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Fazolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Oliveira","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Crispim","family":"da Fontoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9o Souza","family":"Borba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia","family":"Polese-Bonatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciane Beatriz","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato T.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Pawelec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bonorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"758_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.virol.2015.04.004","volume":"483","author":"S-E Wu","year":"2015","unstructured":"Wu S-E, Miller WE (2015) The human cytomegalovirus lytic cycle is induced by 1,25- dihydroxy vitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line. Virology 483:83\u201395","journal-title":"Virology"},{"issue":"1","key":"758_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3195-5","volume":"18","author":"X Li","year":"2018","unstructured":"Li X, Huang Y, Xu Z, Zhang R, Liu X, Li Y et al (2018) Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: A systematic review and meta-analysis. BMC Infect Dis 18(1):1\u201310","journal-title":"BMC Infect Dis"},{"key":"758_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5123\/S2176-62232016000500024","volume":"7","author":"DF Lobato-Silva","year":"2016","unstructured":"Lobato-Silva DF (2016) Citomegalov\u00edrus: epidemiologia baseada em dados de soropreval\u00eancia. Rev Pan-Amaz\u00f4nica Sa\u00fade. 7:213\u20139","journal-title":"Rev Pan-Amaz\u00f4nica Sa\u00fade."},{"issue":"1","key":"758_CR4","first-page":"33","volume":"8","author":"JU Moura","year":"2007","unstructured":"Moura JU, Moraes GB, Capiotti MP, Silva RM, Leal DBR (2007) Preval\u00eancia Sorol\u00f3gica de Anti-CMV Em Gestantes da Regi\u00e3o Oeste de Santa Maria, RS. Disc Scientia Ci\u00eancias da Sa\u00fade, Santa Maria, Brazil. 8(1):33\u20139","journal-title":"Disc Scientia Ci\u00eancias da Sa\u00fade, Santa Maria, Brazil."},{"issue":"4","key":"758_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1590\/S0037-86822010000400004","volume":"43","author":"MA Souza","year":"2010","unstructured":"Souza MA, Passos AM, Treitinger A, Spada C (2010) Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil | Soropreval\u00eancia de anticorpos contra citomegalov\u00edrus em doadores de sangue do Sul do Brasil. Rev Soc Bras Med Trop 43(4):359\u2013361","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"758_CR6","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/aje\/kwq177","volume":"172","author":"ET Roberts","year":"2010","unstructured":"Roberts ET, Haan MN, Dowd JB, Aiello AE (2010) Cytomegalovirus antibody levels, inflammation, and mortality among elderly latinos over 9 years of follow-up. Am J Epidemiol 172(4):363\u2013371","journal-title":"Am J Epidemiol"},{"issue":"10","key":"758_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/aje\/kwq062","volume":"171","author":"GC Wang","year":"2010","unstructured":"Wang GC, Kao WHL, Murakami P et al (2010) Cytomegalovirus infection and the risk of mortality and frailty in older women: A prospective observational cohort study. Am J Epidemiol 171(10):1144\u20131152","journal-title":"Am J Epidemiol"},{"issue":"6","key":"758_CR8","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.4049\/jimmunol.0902890","volume":"184","author":"R Vescovini","year":"2010","unstructured":"Vescovini R, Biasini C, Telera AR et al (2010) Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol 184(6):3242\u20133249","journal-title":"J Immunol"},{"issue":"2","key":"758_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0088538","volume":"9","author":"A Pera","year":"2014","unstructured":"Pera A, Campos C, Corona A et al (2014) CMV latent infection improves CD8+ T response to SEB due to expansion of polyfunctional CD57+ cells in young individuals. PLoS ONE 9(2):1\u20137","journal-title":"PLoS ONE"},{"issue":"2","key":"758_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1189\/jlb.4A0316-112R","volume":"101","author":"A Pera","year":"2017","unstructured":"Pera A, Vasudev A, Tan C, Kared H, Solana R, Larbi A (2017) CMV induces expansion of highly polyfunctional CD4 + T cell subset coexpressing CD57 and CD154. J Leukoc Biol 101(2):555\u2013566","journal-title":"J Leukoc Biol"},{"issue":"6","key":"758_CR11","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.20062363","volume":"204","author":"ML Precopio","year":"2007","unstructured":"Precopio ML, Betts MR, Parrino J et al (2007) Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses. J Exp Med 204(6):1405\u20131416","journal-title":"J Exp Med"},{"issue":"13","key":"758_CR12","first-page":"1","volume":"92","author":"CS Rocha","year":"2018","unstructured":"Rocha CS, Hirao LA, Weber MG et al (2018) Subclinical cytomegalovirus infection is associated with altered host immunity, gut microbiota, and vaccine responses. J Virol 92(13):1\u201318","journal-title":"J Virol"},{"key":"758_CR13","first-page":"1","volume":"20","author":"S Salimi","year":"2020","unstructured":"Salimi S, Hamlyn JM (2020) COVID-19 and Crosstalk With the Hallmarks of Aging. J Gerontol Ser A. 20:1\u20138","journal-title":"J Gerontol Ser A."},{"key":"758_CR14","unstructured":"World Health Organization (2021) WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/"},{"issue":"1","key":"758_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-27120-y","volume":"12","author":"T Fazolo","year":"2021","unstructured":"Fazolo T, Lima K, Fontoura JC et al (2021) Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses. Nat Commun 12(1):1\u201313","journal-title":"Nat Commun"},{"key":"758_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpmc.100","volume":"57","author":"D Stadlbauer","year":"2020","unstructured":"Stadlbauer D, Amanat F, Chromikova V, Krammer F (2020) SARS-CoV-2 seroconversion in humans a detailed protocol for a serological assay, antigen production, and test setup. Curr Protoc Microbiol 57:1\u201315","journal-title":"Curr Protoc Microbiol"},{"issue":"1","key":"758_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-88130-w","volume":"11","author":"B Thakur","year":"2021","unstructured":"Thakur B, Dubey P, Benitez J et al (2021) A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep. 11(1):1\u201313. https:\/\/doi.org\/10.1038\/s41598-021-88130-w","journal-title":"Sci Rep."},{"issue":"2","key":"758_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000513288","volume":"50","author":"M Honardoost","year":"2021","unstructured":"Honardoost M, Janani L, Aghili R, Emami Z, Khamseh ME (2021) The association between presence of comorbidities and COVID-19 severity: a systematic review and meta-analysis. Cerebrovasc Dis 50(2):132\u2013140","journal-title":"Cerebrovasc Dis"},{"key":"758_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-015-0056-6","author":"HM Parry","year":"2016","unstructured":"Parry HM, Zuo J, Frumento G et al (2016) Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immun Ageing. https:\/\/doi.org\/10.1186\/s12979-015-0056-6","journal-title":"Immun Ageing"},{"key":"758_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12890\/2020_001652","volume":"7","author":"D D\u2019Ardes","year":"2020","unstructured":"D\u2019Ardes D, Boccatonda A, Schiavone C et al (2020) A Case of Coinfection with SARS-COV-2 and cytomegalovirus in the Era of COVID-19. EJCRIM 7:1","journal-title":"EJCRIM"},{"issue":"1","key":"758_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03252-3","volume":"24","author":"P Le Balc\u2019h","year":"2020","unstructured":"Le Balc\u2019h P, Pinceaux K, Pronier C, Seguin P, Tadi\u00e9 JM, Reizine F (2020) Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care 24(1):1\u20133","journal-title":"Crit Care"},{"issue":"4","key":"758_CR22","doi-asserted-by":"publisher","first-page":"A772","DOI":"10.1016\/j.chest.2020.08.719","volume":"158","author":"N Jiwa","year":"2020","unstructured":"Jiwa N, Lorick K, Mutneja R (2020) Cytomegalovirus colitis post Il-6 inhibitor use in Covid-19 infection. Chest 158(4):A772. https:\/\/doi.org\/10.1016\/j.chest.2020.08.719","journal-title":"Chest"},{"key":"758_CR23","first-page":"1","volume":"9","author":"S Leemans","year":"2020","unstructured":"Leemans S, Maillart E, Van Noten H et al (2020) Cytomegalovirus hemorrhagic colitis complicating COVID-19 in an immunocompetent critically ill patient: A case report. Clin Case Reports. 9:1\u20135","journal-title":"Clin Case Reports."},{"issue":"1","key":"758_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4084\/mjhid.2020.060","volume":"12","author":"G Marchi","year":"2020","unstructured":"Marchi G, Vianello A, Crisafulli E et al (2020) Cytomegalovirus-induced gastrointestinal bleeding and pancreatitis complicating severe COVID-19 pneumonia: a paradigmatic case. Mediterr J Hematol Infect Dis 12(1):12\u201315","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"4","key":"758_CR25","first-page":"375","volume":"52","author":"CW Pitoyo","year":"2020","unstructured":"Pitoyo CW, Wijaya IPEK, Wulani V, Wiraputri AK, Romulo MA (2020) Misleading diagnosis of radiological imaging of COVID-19 pneumonia during pandemic era: risk on the existence of CMV infection. Acta Med Indones 52(4):375\u2013382","journal-title":"Acta Med Indones"},{"issue":"13","key":"758_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jcm10132792","volume":"10","author":"P Moniz","year":"2021","unstructured":"Moniz P, Brito S, P\u00f3voa P (2021) SARS-CoV-2 and cytomegalovirus co-infections\u2014a case series of critically ill patients. J Clin Med 10(13):2\u20136","journal-title":"J Clin Med"},{"issue":"2","key":"758_CR27","doi-asserted-by":"publisher","first-page":"00062","DOI":"10.1183\/23120541.00062-2020","volume":"6","author":"R Nenna","year":"2020","unstructured":"Nenna R, Zhai J, Packard SE et al (2020) High cytomegalovirus serology and subsequent COPD-related mortality: a longitudinal study. ERJ Open Res. 6(2):00062\u201302020. https:\/\/doi.org\/10.1183\/23120541.00062-2020","journal-title":"ERJ Open Res."},{"issue":"4","key":"758_CR28","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/cmi.2015.4","volume":"13","author":"DAB Tan","year":"2016","unstructured":"Tan DAB, Amran FS, Teo TH, Price P, Moodley YP (2016) Levels of CMV-reactive antibodies correlate with the induction of CD28null T cells and systemic inflammation in chronic obstructive pulmonary disease (COPD). Cell Mol Immunol 13(4):551\u20133. https:\/\/doi.org\/10.1038\/cmi.2015.4","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"758_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0181440","volume":"12","author":"Z Li","year":"2017","unstructured":"Li Z, Tang Y, Tang N et al (2017) High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population. PLoS ONE 12(8):1\u201318","journal-title":"PLoS ONE"},{"issue":"7","key":"758_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.116.005025","volume":"6","author":"H Wang","year":"2017","unstructured":"Wang H, Peng G, Bai J et al (2017) Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): A meta-analysis of prospective studies up to 2016. J Am Heart Assoc 6(7):1\u201310","journal-title":"J Am Heart Assoc"},{"issue":"43","key":"758_CR31","first-page":"1","volume":"62","author":"OA Espinosa","year":"2020","unstructured":"Espinosa OA, Zanetti AS, Antunes EF, Longhi FG, Matos TA, Battaglini PF (2020) Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Rev Inst Med Trop Sao Paulo 62(43):1\u201313","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"6","key":"758_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ni.3742","volume":"18","author":"M Veldhoen","year":"2017","unstructured":"Veldhoen M (2017) Interleukin 17 is a chief orchestrator of immunity. Nat Immunol 18(6):612\u2013621","journal-title":"Nat Immunol"},{"issue":"3","key":"758_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","volume":"135","author":"F Annunziato","year":"2015","unstructured":"Annunziato F, Romagnani C, Romagnani S (2015) The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol 135(3):626\u201335. https:\/\/doi.org\/10.1016\/j.jaci.2014.11.001","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"758_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri2314","volume":"8","author":"AJ Sadler","year":"2008","unstructured":"Sadler AJ, Williams BRG (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8(7):559\u2013568","journal-title":"Nat Rev Immunol"},{"key":"758_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C et al (2020) Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584:463\u2013469","journal-title":"Nature"},{"issue":"June","key":"758_CR36","first-page":"1","volume":"8","author":"JP Hussman","year":"2021","unstructured":"Hussman JP (2021) Severe clinical worsening in COVID-19 and potential mechanisms of immune-enhanced disease. Front Med 8(June):1\u201313","journal-title":"Front Med"},{"issue":"9","key":"758_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/jpm11090891","volume":"11","author":"E Jahaj","year":"2021","unstructured":"Jahaj E, Vassiliou AG, Keskinidou C et al (2021) Evaluating the role of the interleukin-23\/17 axis in critically ill COVID-19 patients. J Pers Med. 11(9):891","journal-title":"J Pers Med."},{"issue":"1","key":"758_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-96110-3","volume":"11","author":"MZ Hasan","year":"2021","unstructured":"Hasan MZ, Islam S, Matsumoto K, Kawai T (2021) SARS-CoV-2 infection initiates interleukin-17-enriched transcriptional response in different cells from multiple organs. Sci Rep 11(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-021-96110-3","journal-title":"Sci Rep"},{"issue":"2","key":"758_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1084\/jem.20082030","volume":"206","author":"W Hou","year":"2009","unstructured":"Hou W, Kang HS, Kim BS (2009) Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 206(2):313\u2013328","journal-title":"J Exp Med"},{"key":"758_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-2567.2011.03520.x","volume":"135","author":"CA Knosp","year":"2011","unstructured":"Knosp CA, Johnston JA (2011) Regulation of CD4+ T-cell polarization by suppressor of cytokine signaling proteins. Immunology 135:101\u2013111","journal-title":"Immunology"},{"issue":"6","key":"758_CR41","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","volume":"52","author":"N Vabret","year":"2020","unstructured":"Vabret N, Britton GJ, Gruber C et al (2020) Immunology of COVID-19: current state of the science. Immunity 52(6):910\u2013941","journal-title":"Immunity"},{"key":"758_CR42","first-page":"1","volume":"37","author":"JH Naendrup","year":"2021","unstructured":"Naendrup JH, Borrega JG, Eichenauer DA, Shimabukuro-Vornhagen A, Kochanek M, B\u00f6ll B (2021) Reactivation of EBV and CMV in severe COVID-19\u2014epiphenomena or trigger of hyperinflammation in need of treatment? a large case series of critically ill patients. J Intensive Care Med. 37:1\u20137","journal-title":"J Intensive Care Med."},{"issue":"6520","key":"758_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/science.abd4250","volume":"370","author":"E Shrock","year":"2020","unstructured":"Shrock E, Fujimura E, Kula T et al (2020) Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity. Science 370(6520):1\u201323","journal-title":"Science"},{"key":"758_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fragi.2021.719342","volume":"2","author":"N Jo","year":"2021","unstructured":"Jo N, Zhang R, Ueno H et al (2021) Aging and CMV infection affect pre-existing SARS-CoV-2-reactive CD8+ T cells in unexposed individuals. Front Aging 2:1\u201316","journal-title":"Front Aging"},{"issue":"281","key":"758_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aaa2293","volume":"7","author":"D Furman","year":"2015","unstructured":"Furman D, Jojic V, Sharma S et al (2015) Cytomegalovirus infection improves immune responses to influenza. Sci Transl Med 7(281):1\u201322","journal-title":"Sci Transl Med"},{"issue":"7142","key":"758_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature05762","volume":"447","author":"ES Barton","year":"2007","unstructured":"Barton ES, White DW, Cathelyn JS et al (2007) Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447(7142):326\u2013329","journal-title":"Nature"},{"issue":"2","key":"758_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jaci.2005.04.027","volume":"116","author":"C Nilsson","year":"2005","unstructured":"Nilsson C, Linde A, Montgomery SM et al (2005) Does early EBV infection protect against IgE sensitization? J Allergy Clin Immunol 116(2):438\u2013444","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"758_CR48","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/rmv.664","volume":"20","author":"AP Limaye","year":"2010","unstructured":"Limaye AP, Boeckh M (2010) CMV in critically ill patients: Pathogen or bystander? Rev Med Virol 20(6):372\u2013379","journal-title":"Rev Med Virol"},{"key":"758_CR49","first-page":"1","volume":"323","author":"S Weber","year":"2021","unstructured":"Weber S, Kehl V, Erber J, Busch DH (2021) CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. medRxiv 323:1\u201319","journal-title":"medRxiv"},{"issue":"36","key":"758_CR50","doi-asserted-by":"publisher","first-page":"14538","DOI":"10.1073\/pnas.1204836109","volume":"109","author":"GM Mason","year":"2012","unstructured":"Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH (2012) Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. PNAS 109(36):14538\u201314543","journal-title":"PNAS"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-022-00758-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-022-00758-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-022-00758-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T23:22:57Z","timestamp":1676330577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-022-00758-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["758"],"URL":"https:\/\/doi.org\/10.1007\/s00430-022-00758-1","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"8 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}